BioSpace News Archive

CureDuchenne, a leading global nonprofit focused on finding and funding a cure for Duchenne muscular dystrophy, announces a webinar to continue educating the Duchenne community about the COVID-19 vaccines.

Samsung Biologics announced a strong year in 2020 as it reported 1 trillion won in target sales within just a decade at its 10th Annual General Meeting on March 19th Korea time.

Health Canada confirms that the benefits of the AstraZeneca COVID-19 vaccine in protecting Canadians from COVID-19 continue to outweigh the risks, and encourages Canadians to get immunized with any of the COVID-19 vaccines that are authorized in Canada.

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs, announced the pricing of its upsized initial public offering of 7,500,000 shares of common stock at a public offering price of $17.00 per share.

With students in nursing, physical therapy, occupational therapy and veterinary science, one thing was clear to Stanbridge University when the coronavirus started shutting down much of the world last spring: their students needed to be back on campus for essential lab and clinical learning, but only if it could be done safely.

After a temporary suspension of AstraZeneca vaccine across several EU countries due to concerns about rare adverse reactions, many nations plan to restart vaccinations following European Medicines Agency’s conclusion that the benefits of the vaccine far outweigh the risks.